Clinical Trials Browser

Phase 1 × Inosine Monophosphate × 90 days × Clear all

NCT04230265 2026-01-22

Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute